These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 7564669)
21. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Anderson G; Noorian AR; Taylor G; Anitha M; Bernhard D; Srinivasan S; Greene JG Exp Neurol; 2007 Sep; 207(1):4-12. PubMed ID: 17586496 [TBL] [Abstract][Full Text] [Related]
22. Nurr1 in Parkinson's disease and related disorders. Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253 [TBL] [Abstract][Full Text] [Related]
23. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211 [TBL] [Abstract][Full Text] [Related]
24. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy. Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399 [TBL] [Abstract][Full Text] [Related]
25. Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease. Awad RA World J Gastroenterol; 2011 Dec; 17(46):5035-48. PubMed ID: 22171138 [TBL] [Abstract][Full Text] [Related]
26. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)? Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716 [TBL] [Abstract][Full Text] [Related]
27. Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle? Sharma A; Kurek J; Morgan JC; Wakade C; Rao SSC Curr Gastroenterol Rep; 2018 Jan; 20(1):1. PubMed ID: 29350301 [TBL] [Abstract][Full Text] [Related]
28. Colonic neuropathological aspects in patients with intractable constipation due to obstructed defecation. Bassotti G; Villanacci V; Nascimbeni R; Asteria CR; Fisogni S; Nesi G; Legrenzi L; Mariano M; Tonelli F; Morelli A; Salerni B Mod Pathol; 2007 Mar; 20(3):367-74. PubMed ID: 17277762 [TBL] [Abstract][Full Text] [Related]
29. Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease. Blandini F; Balestra B; Levandis G; Cervio M; Greco R; Tassorelli C; Colucci M; Faniglione M; Bazzini E; Nappi G; Clavenzani P; Vigneri S; De Giorgio R; Tonini M Neurosci Lett; 2009 Dec; 467(3):203-7. PubMed ID: 19835930 [TBL] [Abstract][Full Text] [Related]
30. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Park HJ; Kamm MA; Abbasi AM; Talbot IC Dis Colon Rectum; 1995 May; 38(5):509-13. PubMed ID: 7736882 [TBL] [Abstract][Full Text] [Related]
32. Enteric neurons from Parkinson's disease patients display ex vivo aberrations in mitochondrial structure. Baumuratov AS; Antony PM; Ostaszewski M; He F; Salamanca L; Antunes L; Weber J; Longhino L; Derkinderen P; Koopman WJ; Diederich NJ Sci Rep; 2016 Sep; 6():33117. PubMed ID: 27624977 [TBL] [Abstract][Full Text] [Related]
33. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831 [TBL] [Abstract][Full Text] [Related]
34. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230 [TBL] [Abstract][Full Text] [Related]
35. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease. Gai WP; Vickers JC; Blumbergs PC; Blessing WW J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375 [TBL] [Abstract][Full Text] [Related]
37. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
38. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Damier P; Hirsch EC; Agid Y; Graybiel AM Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830 [TBL] [Abstract][Full Text] [Related]
39. Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation. Faussone-Pellegrini MS; Infantino A; Matini P; Masin A; Mayer B; Lise M Histol Histopathol; 1999 Oct; 14(4):1119-34. PubMed ID: 10506928 [TBL] [Abstract][Full Text] [Related]
40. Enteric glial cells: new players in Parkinson's disease? Clairembault T; Leclair-Visonneau L; Neunlist M; Derkinderen P Mov Disord; 2015 Apr; 30(4):494-8. PubMed ID: 25100667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]